Background Invasive fungal infections (IFI) mainly caused by aspergillus species are one of
the leading causes of death in patients undergoing immunosuppressive therapy for …

Rationale: Invasive fungal disease (IFD) is a significant cause of morbidity and mortality in
immunocompromised patients. Objectives: We hypothesize that galactomannan (GM), a …

Background Although bronchoalveolar lavage (BAL) measurements of galactomannan
antigen (GM) seems to be more sensitive than serum testing to detect invasive fungal …

Introduction. Evidence for the clinical utility of bronchoalveolar lavage (BAL) galactomannan
in the management of fungal disease outside of haemato-oncology patients is limited. Aim …

Background: Invasive aspergillosis (IA) is the most prevalent invasive infection with high
mortality among patients with leukemia. Early diagnosis of IA has been a challenging topic …

Pulmonary infections are a major cause of morbidity and mortality in patients with
hematologic malignancy. Bronchoscopy is at present still the traditional first investigation in …

We conducted a single-center retrospective cohort study to determine the performance
characteristics of the galactomannan (GM) assay in bronchoalveolar lavage (BAL) in …

INTRODUCTION: Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and
mortality in patients with hematological malignancies. In recent years, testing for values of …

BACKGROUND: We evaluated the performance of a galactomannan (GM) assay in
bronchoalveolar lavage (BAL) fluid compared to serum samples for the diagnosis of invasive …

Objective To evaluate the feasibility of the serum galactomannan (GM) assay as a rapid
detection method for the early diagnosis of invasive fungal infections (IFI) in haematological …